Sign in
4

Changes in Ownership

Organon & Co. Filed Acc 0001209191-23-023087

Chief Financial Officer gave up 2,656 shares (to pay taxes)

  • Chief Financial Officer acquired 7,753 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
WALSH MATTHEW M Chief Financial Officer 2023-03-31 Option exercise +7,753 39,459 D
WALSH MATTHEW M Chief Financial Officer 2023-03-31 Shares withheld for taxes −2,656 $23.09 $61,327 36,803 D
Derivatives
WALSH MATTHEW M Chief Financial Officer 2023-03-31 Option exercise · Restricted Stock Units −7,753 15,507 D
WALSH MATTHEW M Chief Financial Officer 2023-03-31 Grant or award · Restricted Stock Units +36,139 36,139 D
WALSH MATTHEW M Chief Financial Officer 2023-03-31 Grant or award · Stock Option (right to buy) +129,770 129,770 D
Loading xslF345X04/doc4.xml…